Lincoln Pharma schedules 32nd AGM for Sept 30, announces dividend
Lincoln Pharmaceuticals Limited will hold its 32nd AGM on September 30, 2026, via VC/OAVM. The company recommended a dividend of ₹1.80 per share for FY26, subject to member approval. The Register of Members will close from Sept 12-30, 2026. Remote e-voting is available from Sept 26-29, 2026.
The announcement involves the AGM, book closure, and dividend recommendation, which are important for shareholders but do not represent a significant new business development or financial change that would have a high impact.
The announcement details the upcoming AGM and a recommended dividend, which are routine corporate actions and generally viewed positively by shareholders.
Lincoln Pharmaceuticals Limited has announced its 32nd Annual General Meeting (AGM) will be held on Wednesday, September 30, 2026, at 11:00 a.m. IST, through Video Conference (VC) / Other Audio Visual Means (OAVM).
The company's Annual Report for the financial year 2025-26 and the AGM Notice are being sent exclusively through electronic mode to members whose email addresses are registered with the company or depositories. For shareholders whose email IDs are not registered, a weblink to the company's website will be provided to access the Annual Report. Both the Notice and Annual Report are also available on the company's website (www.lincolnpharma.com) and the websites of BSE (www.bseindia.com) and NSE (www.nseindia.com).
The Register of Members and Share Transfer Book will remain closed from Saturday, September 12, 2026, to Wednesday, September 30, 2026, inclusive. This closure is for determining the eligibility of members to receive the final dividend for the year ended March 31, 2026, subject to approval at the AGM.
The Board of Directors, in its meeting held on May 28, 2026, recommended a dividend of ₹1.80 per equity share of face value ₹10 each (18%) for the year ended March 31, 2026. This dividend, if approved by the members, will be paid within 30 days. Members are reminded that dividends paid after April 01, 2020, are taxable in their hands, and the company will deduct Tax Deducted at Source (TDS) if the amount exceeds ₹10,000. To avail of any benefit of non-deduction of TDS, members must upload a duly signed Form 121 by September 10, 2026.
Lincoln Pharmaceuticals is providing a remote e-voting facility through CDSL. The remote e-voting period will commence on Saturday, September 26, 2026, at 9:00 a.m. IST and conclude on Tuesday, September 29, 2026, at 5:00 p.m. IST. Members whose names appear on the cut-off date, Wednesday, September 23, 2026, are entitled to vote. Members who have already voted remotely can attend the AGM but cannot vote again. Queries regarding e-voting or AGM participation can be directed to helpdesk.evoting@cdslindia.com or by phone.
What to do with a filing like this
Lincoln Pharmaceuticals Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Lincoln Pharmaceuticals Limited. Read the original for the full detail.